Interpace Diagnostics Changes Name to Interpace Biosciences; Announces Plans for Next Phase of Growth and Third Quarter 2019 Financial Results Nov 13, 2019
Interpace to Host Conference Call and Webcast to Discuss Third Quarter 2019 Financial Results on Wednesday, November 13, 2019 Nov 12, 2019
Interpace Announces Closing of $13 Million Second Tranche Acquisition Financing from Ampersand Capital Partners Oct 17, 2019
Interpace Enters Strategic Partnership Agreement with Genecast Biotechnology to Partner with Biopharma Solutions in China Sep 16, 2019